Maternal cigarette smoking during pregnancy is associated with downregulation of miR-16, miR-21 and miR-146a in the placenta

Epigenetics

Volumn 5, Issue 7, 2010, Pages 583-589

  Maccani, Matthew A ^a   Avissar Whiting, Michele ^a   Banister, Carolyn E ^a   McGonnigal, Bethany ^b   Padbury, James F ^b   Marsit, Carmen J ^a,c  

^a Department of Pathology and Laboratory Medicine ^*  (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

Benzo(a)pyrene; Cigarette smoking; Epigenetics; miRNA; Nicotine; Placenta

Indexed keywords

BENZO[A]PYRENE; MICRORNA; MICRORNA 146A; MICRORNA 16; MICRORNA 182; MICRORNA 21; NICOTINE; UNCLASSIFIED DRUG;

ARTICLE; CELL IMMORTALIZATION; CELL LINE; CIGARETTE SMOKING; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; MALE; MATERNAL SMOKING; PLACENTA; PREGNANCY; PROTEIN EXPRESSION; RNA ANALYSIS;

EID: 78449244510     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.5.7.12762     Document Type: Article

References (50)

1. Lambers DS, Clark KE. The maternal and fetalphysiologic effects of nicotine. Semin Perinatol 1996;20:115-26.
2. Beattie JO. Transplacental alcohol intoxication. AlcoholAlcohol 1986; 21:163-6.
3. Guyda HJ, Mathieu L, Lai W, Manchester D, Wang SL, Ogilvie S, et al. Benzo(a)pyrene inhibits epidermal growth factor binding and receptor autophosphorylation in human placental cell cultures. Mol Pharmacol 1990; 37:137-43.
4. Castles A, Adams EK, Melvin CL, Kelsch C, BoultonML. Effects of smoking during pregnancy. Five meta-analyses. Am J Prev Med 1999; 16:208-15.
5. Shah NR, Bracken MB. A systematic review andmeta-analysis of prospective studies on the associationbetween maternal cigarette smoking and preterm deliv-ery. Am J Obstet Gynecol 2000; 182:465-72.
6. Kaddar T, Rouault JP, Chien WW, Chebel A, Gadoux M, Salles G, et al. Two new miR-16 targets: caprin-1and HMGA1, proteins implicated in cell proliferation. Biol Cell 2009; 101:511-24.
7. Einarson A, Riordan S. Smoking in pregnancy andlactation: a review of risks and cessation strategies. EurJ Clin Pharmacol 2009; 65:325-30.
8. Thielen A, Klus H, Muller L. Tobacco smoke: unravel-ing a controversial subject. Exp Toxicol Pathol 2008;60:141-56.
9. Mohsin M, Bauman AE. Socio-demographic factorsassociated with smoking and smoking cessation among4,26,344 pregnant women in New South Wales,Australia. BMC Public Health 2005; 5:138.
10. Jaakkola N, Jaakkola MS, Gissler M, Jaakkola JJ.Smoking during pregnancy in Finland: determinantsand trends 1987-1997. Am J Public Health 2001;91:284-6.
11. Cnattingius S. The epidemiology of smoking duringpregnancy: smoking prevalence, maternal characteris-tics and pregnancy outcomes. Nicotine Tob Res 2004;6:125-40.
12. Goodwin RD, Keyes K, Simuro N. Mental disordersand nicotine dependence among pregnant women inthe United States. Obstet Gynecol 2007; 109:875-83.
13. Lee RC, Feinbaum RL, Ambros V. The C. elegans heter-ochronic gene lin-4 encodes small RNAs with antisensecomplementarity to lin-14. Cell 1993; 75:843-54.
14. Du T, Zamore PD. Beginning to understand microR-NA function. Cell Res 2007; 17:661-3.
15. Miska EA. How microRNAs control cell division, dif-ferentiation and death. Curr Opin Genet Dev 2005;15:563-8.
16. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S,Barad O, et al. Identification of hundreds of conserved and non conserved human microRNAs. Nat Genet 2005; 37:766-70.
17. Lehnert S, Van Loo P, Thilakarathne PJ, MarynenP, Verbeke G, Schuit FC. Evidence for co-evolutionbetween human microRNAs and Alu-repeats. PLoSOne 2009; 4:4456.
18. Zhang R, Wang YQ, Su B. Molecular evolution of a primate-specific micro RNA family. Mol Biol Evol 2008; 25:1493-502.
19. Tsai KW, Kao HW, Chen HC, Chen SJ, Lin WC. Epigenetic control of the expression of a primate-specific microRNA cluster in human cancer cells. Epigenetics 2009; 4:587-92
20. Hutvagner G, Zamore PD. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002;297:2056-60.
21. Hu HY, Yan Z, Xu Y, Hu H, Menzel C, Zhou YH, etal. Sequence features associated with microRNA strandselection in humans and flies. BMC Genomics 2009;10:413
22. Pineles BL, Romero R, Montenegro D, Tarca AL, Han YM, Kim YM, et al. Distinct subsets of microRNAsare expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol 2007; 196:261-6.
23. Marsit CJ, Eddy K, Kelsey KT. MicroRNA responses tocellular stress. Cancer Res 2006; 66:10843-8.
24. Avissar-Whiting M, Veiga K, Uhl K, Maccani M,Gagne L, Moen E, et al. Bisphenol A exposure leadsto specific microRNA alterations in placental cells.Reprod Toxicol 2010;29:401-6.
25. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, JacobST, Patel T. MicroRNA-21 regulates expression of thePTEN tumor suppressor gene in human hepatocellularcancer. Gastroenterology 2007; 133:647-58.
26. Tran N, McLean T, Zhang X, Zhao CJ, Thomson JM,O'Brien C, et al. MicroRNA expression profiles inhead and neck cancer cell lines. Biochem Biophys ResCommun 2007; 358:12-7.
27. Rom S, Rom I, Passiatore G, Pacifici M, RadhakrishnanS, Del Valle L, et al. CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEBJ 2010; 24:2292-300.
28. Taganov KD, Boldin MP, Chang KJ, Baltimore D.N Fkappa B-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins ofinnate immune responses. Proc Natl Acad Sci USA 2006; 103:12481-6.
29. Hou J, Wang P, Lin L, Liu X, Ma F, An H, et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1 and IRAK2. J Immunol 2009;183:2150-8.
30. Curtale G, Citarella F, Carissimi C, Goldoni M, Carucci N, Fulci V, et al. An emerging player inthe adaptive immune response: microRNA-146a is amodulator of IL-2 expression and activation-inducedcell death in T lymphocytes. Blood 2010; 115:265-73.
31. Wang JF, Yu ML, Yu G, Bian JJ, Deng XM, Wan XJ, et al. Serum miR-146a and miR-223 as potential new biomarkers for sepsis. Biochem Biophys Res Commun 2010; 394:184-8
32. Pothof J, Verkaik NS, van IW, Wiemer EA, Ta VT, van der Horst GT, et al. MicroRNA-mediated gene silenc-ing modulates the UV-induced DNA-damage response.EMBO J 2009; 28:2090-9.
33. Weber M, Baker MB, Moore JP, Searles CD. MiR-21 isinduced in endothelial cells by shear stress and modu-lates apoptosis and eNOS activity. Biochem BiophysRes Commun 2010; 393:643-8
34. Wang P, Zou F, Zhang X, Li H, Dulak A, Tomko RJ Jr, et al. microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res 2009; 69:8157-65.
35. Zhang L, Connor EE, Chegini N, Shiverick KT. Modulation by benzo[a]pyrene of epidermal growth factor receptors, cell proliferation and secretion ofhuman chorionic gonadotropin in human placental celllines. Biochem Pharmacol 1995; 50:1171-80.
36. Genbacev O, McMaster MT, Lazic J, Nedeljkovic S, Cvetkovic M, Joslin R, et al. Concordant in situ andin vitro data show that maternal cigarette smokingnegatively regulates placental cytotrophoblast passagethrough the cell cycle. Reprod Toxicol 2000; 14:495-506.
37. Crawford M, Batte K, Yu L, Wu X, Nuovo GJ, Marsh CB, et al. MicroRNA 133B targets pro-survival mol-ecules MCL-1 and BCL2L2 in lung cancer. BiochemBiophys Res Commun 2009; 388:483-9.
38. Fabian D, Cikos S, Koppel J. Gene expression in mousepreimplantation embryos affected by apoptotic induc-tor actinomycin D. J Reprod Dev 2009; 55:576-82.
39. Esibizione D, Cui CY, Schlessinger D. Candidate EDA targets revealed by expression profiling of primarykeratinocytes from Tabby mutant mice. Gene 2008;427:42-6.
40. Qian Y, Commane M, Ninomiya-Tsuji J, Matsumoto K, Li X. IRAK-mediated translocation of TRAF6and TAB2 in the interleukin-1-induced activation ofNFkappaB. J Biol Chem 2001; 276:41661-7.
41. Wang Q, Dziarski R, Kirschning CJ, Muzio M, Gupta D. Micrococci and peptidoglycan activate TLR2→MyD88→IRAK→TRAF→NIK→IKK→NFkappaBsignal transduction pathway that induces transcriptionof interleukin-8. Infect Immun 2001; 69:2270-6.
42. Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, Hacker H, et al. Endocytosed HSP60suse toll-like receptor 2 (TLR2) and TLR4 to activatethe toll/interleukin-1 receptor signaling pathway ininnate immune cells. J Biol Chem 2001; 276:31332-9.
43. Li L, Kang J, Lei W. Role of Toll-like receptor 4 ininflammation-induced preterm delivery. Mol HumReprod 2010; 16:267-72.
44. Nakao S, Ogata Y, Sugiya H. Nicotine stimulates the expression of cyclooxygenase-2 mRNA via NF kappaB activation in human gingival fibroblasts. Arch Oral Biol 2009; 54:251-7.
45. Perry MM, Williams AE, Tsitsiou E, Larner-Svensson HM, Lindsay MA. Divergent intracellular pathways regulate interleukin-1beta-induced miR-146a and miR-146b expression and chemokine release in humanalveolar epithelial cells. FEBS Lett 2009; 583:3349-55.
46. Russell MA, Jarvis M, Iyer R, Feyerabend C. Relationof nicotine yield of cigarettes to blood nicotine concen-trations in smokers. Br Med J 1980; 280:972-6.
47. Waggoner SE, Wang X. Effect of nicotine on proliferation of normal, malignant and human papillomavirus-transformed human cervical cells. Gynecol Oncol 1994; 55:91-5
48. CIP1and p53 phosphorylation in human choriocarcinomaJEG-3 cells: a distinct signaling pathway. Placenta 2005; 26:87-95.
49. Lall S, Grun D, Krek A, Chen K, Wang YL, DeweyCN, et al. A genome-wide map of conserved microR-NA targets in C. elegans. Curr Biol 2006; 16:460-71.
50. Kruger J, Rehmsmeier M. RNAhybrid: microRNAtarget prediction easy, fast and flexible. Nucleic AcidsRes 2006; 34:451-4.